We and others have previously shown that inhibition of iNOS by gene disruption or pharmacological inhibitors ameliorates obesity- and stress (i.e., burn, lipopolysaccharide [LPS])-induced insulin resistance in rodents [10–14]. The gene discussed is NOS2; the disease is obesity due to melanocortin 4 receptor deficiency.